ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Heart/lung transplantation"

  • 2015 American Transplant Congress

    Upregulation of Heart Transplant IL-33 Is Critical in Cardiac Tissue Repair

    Q. Liu, L. Mathews, J. Lott, B. Matta, H. Turnquist.

    Starzl Transplantation Institute, Department of Surgery, Univ of Pittsburgh, Pittsburgh, PA.

    Background: IL-33 is tissue-derived cytokine whose primary proposed function is to modulate immune responses when released during injury. Delivery of recombinant IL-33 protects cardiac allografts…
  • 2015 American Transplant Congress

    Factors Influencing Cost Among Kidney, Liver, and Heart Transplant Patients in a Private Payer Setting

    W. Bannister,1 C. Wu,1 M. Schnitzler,2 F. Irwin,1 A. Bonagura.1

    1Optum, Minneapolis; 2Saint Louis University, St. Louis.

    The factors influencing cost in solid organ transplantation have been evaluated by many individual centers, as well as nationally for Medicare patients. However, the majority…
  • 2015 American Transplant Congress

    Induction of HO-1 High Expression Enhances the Capacity of Immature Dendritic Cells to Modulate Alloimmune Responses

    G. Chen, Y. Zhao, L. Wang, S. Chen, X. Huang.

    Institute of Organ Transplantation, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China.

    Background: It has been reported that HO-1 is critical for tolerogenic dendritic cells (tolDCs) to suppress T cell responses and tolDCs will lost their immunoregulatory…
  • 2015 American Transplant Congress

    Murine Veno-Arterial Extracorporeal Membrane Oxygenation (mVA-ECMO): A Novel Tool to Study the Molecular Biology of Mechanical Circulatory Support

    A. Schenk,1 J. Fallon,1 M. Farrell,1 R. Halter,2 J. Yun.3

    1Surgery, Dartmouth Hitchcock Medical Center, Lebanon, NH; 2Thayer School of Engineering, Dartmouth College, Hanover, NH; 3Cardiothoracic Surgery, Yale New-Haven Hospital, New Haven, CT.

    PURPOSE: In recent years, clinical use of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) has grown. Extracorporeal circulation is an essential component of heart and lung transplantation,…
  • 2015 American Transplant Congress

    Anti-BTLA Antibody (6B2) Induced Prolongation of Fully MHC-Mismatched Murine Cardiac Allograft and Generation of Foxp3+ Regulatory T Cells

    M. Uchiyama,1,2,3 E. Yin,3,4 X. Jin,3,5 T. Shimokawa,1 H. Yagita,2 M. Niimi.3

    1Cardiovascular Surgery, Teikyo University, Tokyo, Japan; 2Immunology, Juntendo University Hospital, Tokyo, Japan; 3Surgery, Teikyo University, Tokyo, Japan; 4Cardiovascular Surgery, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; 5Cardiovascular and Thoracic Surgery, The 4th Affiliated Hospital of Harbin Medical University, Harbin, China.

    Background: The co-inhibitory receptor B and T lymphocyte attenuator (BTLA; CD272) has been implicated in the regulation of autoimmune and may potentially play an important…
  • 2015 American Transplant Congress

    Indefinite Survival of Fully MHC-Mismatched Murine Cardiac Allografts by Combination of Anti-BTLA mAb (6B2) and Anti-PD-1 mAb (PIM-2)

    E. Yin,1,2 M. Uchiyama,1,3,4 X. Jin,1,5 T. Shimokawa,3 H. Yagita,4 M. Niimi.1

    1Department of Surgery, Teikyo University, Tokyo, Japan; 2Department of Cardiovascular Surgery, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China; 3Department of Cardiovascular Surgery, Teikyo University, Tokyo, Japan; 4Department of Immunology, Juntendo University Hospital, Tokyo, Japan; 5Department of Cardiovascular and Thoracic Surgery, The 4th Affiliated Hospital of Harbin Medical University, Harbin, China.

    Background: The co-inhibitory receptor B and T lymphocyte attenuator (BTLA) and Programmed death (PD)-1 had been suggested to have immunomodulatory activity. This study investigated the…
  • 2015 American Transplant Congress

    Recipient Myelomonocytic Cells With Activated Hypoxia-Inducible Factor Alleviate Ischemia-Reperfusion Injury in Mouse Heart Allografts

    A. Raissadati, M. Keränen, E. Rouvinen, R. Krebs, K. Lemström.

    Transplantation Laboratory and Department of Cardiac Surgery, University of Helsinki, Haartman institute and Helsinki University Central Hospital, Heart and Lung Center, Helsinki, Finland.

    Aim: To investigate the effect of HIF-1α and -2α activation in myelomonocytic cells during the early phase after ischemia-reperfusion (IRI) injury of mouse allogenic heart…
  • 2015 American Transplant Congress

    Identification of CXCR5+EBV-Specific CD8+ T Cells in Peripheral Blood of Pediatric Heart Transplant Recipients Correlates With IL-21 Production and EBV Reactivation

    C. Macedo,1 K. Hadi,1 D. Rowe,2 J. Luce,3 S. Webber,4 B. Feingold,3 D. Metes.1

    1Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh; 2Infectious Diseases and Microbiology, University of Pittsburgh, Pittsburgh; 3Pediatrics-Cardiology, Children's Hospital of Pittsburgh of UPMC, Pittsburgh; 4Pediatrics, Vanderbilt University School of Medicine, Nashville.

    Approximately 70% of EBV asymptomatic pediatric heart transplant (HTx) recipients carry chronic EBV loads in peripheral blood. These EBV loads may occur due to impaired…
  • 2015 American Transplant Congress

    Examining Long-Term Survivors in Combined Heart-Lung Transplantation

    S. Kadakia,1 S. Jayarajan,1 S. Taghavi,1 V. Ambur,1 C. Lewis,1 A. Shiose,2 G. Wheatley III,2 L. Kaiser,3 T. Guy,2 Y. Toyoda.2

    1Department of Surgery, Temple University Hospital, Philadelphia, PA; 2Division of Cardiovascular Surgery, Temple University Hospital, Philadelphia, PA; 3Division of Thoracic Surgery, Temple University Hospital, Philadelphia, PA.

    The goal of this study was to determine variables associated with mortality in combined heart-lung transplantation (HLT).The United Network for Organ Sharing (UNOS) database was…
  • 2015 American Transplant Congress

    Liver Allograft Provides Immunoprotection for the Cardiac Allograft in Combined Heart-Liver Transplantation

    T. Wong, J. Stulak, J. Heimbach, M. Stegall, T. Taner.

    Mayo Clinic, Rochester, MN.

    When transplanted simultaneously, the liver allograft has been thought to have an immunoprotective role on other organs. However, detailed studies on simultaneous heart-liver transplantation (SHLT)…
  • « Previous Page
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences